Published in Adv Nutr on January 17, 2017
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med (1994) 16.96
Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 10.88
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst (1996) 5.63
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol (2003) 5.22
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol (2014) 4.34
Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health (2013) 4.28
Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? Ophthalmology (2014) 4.00
Essential fatty acids in health and chronic disease. Am J Clin Nutr (1999) 3.99
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health (2014) 3.95
The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2006) 3.60
Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA (2013) 3.53
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol (2001) 3.49
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol (1994) 3.25
Age-related macular degeneration is the leading cause of blindness... JAMA (2004) 3.18
Senile macular degeneration: a case-control study. Am J Epidemiol (1983) 3.04
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res (2005) 3.03
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Oxidative damage and age-related macular degeneration. Mol Vis (1999) 2.97
The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci (2000) 2.92
Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89
Structure and properties of carotenoids in relation to function. FASEB J (1995) 2.85
Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology (1999) 2.80
beta-Carotene: an unusual type of lipid antioxidant. Science (1984) 2.76
Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr (2013) 2.75
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. Ophthalmology (2014) 2.29
Distribution of copper and zinc in mammalian eyes. Occurrence of metals in melanin fractions from eye tissues. Biochem J (1952) 2.28
Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25
Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol (1999) 2.25
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol (1993) 2.24
Risk factors for age-related macular degeneration. Prog Retin Eye Res (2001) 2.22
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr (1995) 2.21
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol (2006) 2.21
Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc (1977) 2.20
Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96
Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA (2005) 1.94
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol (1998) 1.93
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology (2007) 1.90
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol (1993) 1.81
Oxy-radicals and cancer. Lancet (1994) 1.80
Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci (1993) 1.68
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology (2012) 1.66
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol (1998) 1.65
Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr (2001) 1.64
Beta-carotene, carotenoids, and disease prevention in humans. FASEB J (1996) 1.61
Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem (2004) 1.60
Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med (2012) 1.59
Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol (2001) 1.59
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol (2006) 1.55
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol (2014) 1.51
Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology (2002) 1.51
Dietary factors that affect the bioavailability of carotenoids. J Nutr (2000) 1.47
Early age-related maculopathy in the cardiovascular health study. Ophthalmology (2003) 1.47
Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res (2001) 1.46
Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci (2001) 1.45
Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry (2011) 1.43
Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ (2002) 1.41
Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand (1998) 1.39
Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci (2006) 1.39
Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res (2008) 1.36
Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol (1999) 1.35
Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology (1999) 1.33
Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res (1990) 1.31
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci (2002) 1.28
Choroidal neovascularization. Ophthalmology (1986) 1.27
Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci (2003) 1.25
Macular pigment and visual performance under glare conditions. Optom Vis Sci (2008) 1.23
Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol (2008) 1.21
Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc U K (1980) 1.20
Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology (1998) 1.20
Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol (2009) 1.20
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res (2006) 1.19
Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch Biochem Biophys (2008) 1.18
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. Arch Ophthalmol (2001) 1.15
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology (2012) 1.13
Retinal light damage reduces autofluorescent pigment deposition in the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1989) 1.10
The singlet oxygen and carotenoid interaction. J Photochem Photobiol B (1991) 1.09
Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys (2001) 1.05
Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol (2009) 1.05
The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol (2010) 1.04
Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative. Arch Ophthalmol (2009) 1.02
Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr (2007) 1.02
Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. Heart Lung Circ (2015) 1.00